US Archives - Page 49 of 80 - European Medical Journal

A Global Approach to Tackling Emerging Infectious Diseases

THE PAST two decades have been marked by the accelerated emergence and re-emergence of infectious diseases worldwide, challenging the…

IDWeek 2024 Interview: Jacqueline Toia and Kathleen Murtagh

Typical? Every day is different, that is part of the Infectious Diseases (ID) magic. We tend to start each day by individually completing…

Rabies Encephalitis: MRI Findings and Predicted Probability of Abnormality Detection

Rabies is a highly lethal infectious disease and is equivalent to a death sentence for patients. The ante-mortem diagnostic sensitivity is…

Immunological Profile of HTLV-1 in Pediatric Patients

Human T-lymphotropic virus type 1 (HTLV-1) is a retrovirus associated with significant immunological dysregulation and oncogenesis…

Clinico-Epidemiological Characteristics and Diagnostics With Autopsy Findings of Rabies Encephalitis

Rabies is the deadliest infectious disease, with a nearly 100% fatality. Due to this fear, it is often an overlooked disease, resulting…

Genomic Test Guides Breast Cancer Therapy Duration

A recent analysis of the IDEAL clinical trial highlights a breakthrough for early-stage breast cancer.

Cancer Risk Elevated in Multiple Sclerosis: New Findings

Patients with multiple sclerosis (MS) may experience a slightly increased risk of developing cancer compared to the general population, according to a new nationwide French study spanning 10 years.

OSA Severity Linked to Postoperative Complications

Obstructive sleep apnea (OSA) severity may hold the key to predicting postoperative cardiorespiratory complications, according to a new study involving over 6,700 patients.

Hydrocortisone Fiber Patch: A 24-Hour Skin Solution

A cutting-edge alternative to traditional skin creams offers a promising new approach for treating inflammatory skin diseases.

New Pathway for OA Treatment: ACR24

Sodium channels in cartilage cells may hold the key to treating osteoarthritis (OA), a new study presented at ACR Convergence 2024 unveiled.